Print
Professionals
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Name
Advanced Search…
Government Experience…
Practices & Industries
Litigation & Trial
Regulatory & Policy
Transactions & Corporate
Investigations
Digital Transformation and Technology
Coronavirus Resource Center
Industries
C&M International
View All Practices & Industries
Locations
Brussels
Doha
London
Los Angeles
New York
Orange County
San Francisco
Shanghai
Washington, D.C.
C&M International
Singapore
Washington, D.C.
News & Events
Events
Firm News & Announcements
Client Alerts & Newsletters
Media Mentions
Publications
Social Media & Blogs
Speeches & Presentations
Podcasts
Creating Tomorrow Series
Coronavirus Resource Center
Biden First 100 Days
Litigation Forecast 2021
About
Overview
Leadership
Awards
Innovation in Service
Diversity & Inclusion
Pro Bono
Careers
Lawyers
Law Students
Professionals
Professionals
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Name
Location
All Locations
Brussels
Doha
London
Los Angeles
New York
Orange County
San Francisco
Shanghai
Singapore
Washington, D.C.
Practice
All Practices
Litigation & Trial
Regulatory & Policy
Transactions & Corporate
Administrative Law & Regulatory
Advertising & Media
Antitrust & Competition
Appellate
Arbitration
Aviation
Bankruptcy & Creditors' Rights
Blockchain / Distributed Ledger Technology (DLT)
Brand & Content Protection
Broker-Dealer
Business Aviation
C&M International
Class Actions
Commercial Contracts & Outsourcing
Commercial Finance & Lending
Commercial Litigation
Commercial Real Estate
Coronavirus (COVID-19) Response Team
Corporate
Corporate Counseling, Governance & Compliance
Derivatives
Digital Health/MedTech
Digital Transformation and Technology
Distressed Debt & Claims Trading
E-Discovery & Information Management
Education
Emerging Companies & Venture Capital
Energy
Environment & Natural Resources
Environmental, Social, and Governance
ERISA & Employee Benefits
European (EU) Regulatory
Executive Practice
False Claims Act
Financial Institutions
Financial Services
Foreign Corrupt Practices Act
Government Affairs
Government Contracts
Government Contracts Transactions
Health Care
Infrastructure
Insurance/Reinsurance
Intellectual Property
International Dispute Resolution
International Trade
Investigations
Investigations: Government & Internal
Investment Funds
Israel Practice
Joint Ventures & Strategic Alliances
Labor & Employment
Latin America Practice
Legal Ethics & Malpractice
Life Sciences
Litigation Finance
Mass Tort, Product, and Consumer Litigation
Mergers & Acquisitions
Middle East and North Africa (MENA) Practice
National Coordinating Counsel & Complex Litigation
National Security
Nonprofit & Tax-Exempt Organizations
Plaintiff's Recovery
Privacy & Cybersecurity
Private Equity
Product Risk Management
Public-Private Partnerships
Restructuring & Creditors' Rights
SEC Enforcement
Securities
State Attorneys General Practice
Tax
Trade Secrets
Transportation
Trial
Whistleblower
White Collar & Regulatory Enforcement
Industry
All Industries
3D Printing
Aerospace & Defense
Agriculture
Artificial Intelligence and Robotics
Automotive & Trucking
Autonomous Vehicles
Aviation
Chemicals
Education
Energy
Financial Services
Food & Beverage
Government Contracts
Health Care
Hospitality & Leisure
Insurance/Reinsurance
Mining
Pharmaceuticals & Life Sciences
Retail & Consumer Products
Technology, Media & Telecommunications
Trade Associations
Transportation
Advanced Search…
Government Experience…
Practices & Industries
Litigation & Trial
Regulatory & Policy
Transactions & Corporate
Investigations
Digital Transformation and Technology
Coronavirus Resource Center
Industries
C&M International
View All Practices & Industries
Search By Name
Locations
Brussels
Doha
London
Los Angeles
New York
Orange County
San Francisco
Shanghai
Washington, D.C.
C&M International
Singapore
Washington, D.C.
News & Events
Events
Firm News & Announcements
Client Alerts & Newsletters
Media Mentions
Publications
Social Media & Blogs
Speeches & Presentations
Podcasts
Creating Tomorrow Series
Coronavirus Resource Center
Biden First 100 Days
Litigation Forecast 2021
About
Overview
Leadership
Awards
Innovation in Service
Diversity & Inclusion
Pro Bono
Careers
Lawyers
Law Students
Professionals
News & Events
Events
Firm News & Announcements
Client Alerts & Newsletters
Media Mentions
Publications
Speeches & Presentations
Subscribe
Social Media & Blogs
Search NewsRoom
Advanced Search
>
Media Contacts
−
+
Rebecca Carr
Director of PR,
Media & Communications
rcarr@crowell.com
+1 202.508.8835
An Pham
Senior Manager, Media, PR & Communications
apham@crowell.com
+1 202.508.8740
Christine
Elfmann
Manager, Marketing Communications
celfmann@crowell.com
+1 202.508.8848
Mass Tort, Product, and Consumer Litigation Alerts
RSS
Mar.26.2021
The Supreme Court Rejects "Causation-Only" Test for Specific Jurisdiction
Mar.24.2021
NHTSA Proposes Rule on Safe Deployment of Self-Driving Vehicles
Feb.09.2021
GAO Calls on FDA to Prepare to Resume Inspections of Drug Manufacturers
Jan.12.2021
Florida’s New Year’s Resolution: A "More Rational, More Fair, and More Consistent" Summary Judgment Standard
Jan.08.2021
Appliance Manufacturers Should Prepare for Increased DOE Enforcement Activity
Dec.21.2020
Transition 2021: Top Transportation Policy Issues Facing the Biden Administration
Dec.07.2020
NHTSA Seeks Guidance on Regulating the Safe Deployment of Self-Driving Vehicles
Nov.05.2020
FDA Postpones DSCSA Provision Enforcement by Three Years
Oct.09.2020
FDA Warning Letter Sends Pointed Message to Industry about EUAs and Compliance
Oct.02.2020
Proposed Legislation Would Expand FDA Authority Over Counterfeit Medical Devices
Sep.03.2020
Maryland Joins "Supermajority" of States Adopting
Daubert
Standard
Jul.17.2020
FDA Plans to Resume Domestic Facility Inspections
Jul.10.2020
FinCEN Provides Additional Guidance for Financial Institutions on Hemp-Related Businesses
Jun.23.2020
FDA Advises Consumers to Avoid Hand Sanitizers Found to Contain Methanol
May.29.2020
Eleventh Circuit Holds that Plaintiff Lacks Standing in Cheerios Glyphosate Lawsuit
May.27.2020
HHS Advisory Opinion Clarifies PREP Act Preemption Measures and Protection for Pharmacists
May.26.2020
Post COVID-19: FDA Regulatory Considerations for Face Mask and PPE Companies
May.15.2020
Re-Thinking Dining in the Age of COVID-19: Follow FDA Best Practices for Re-Opening Retail Food Establishments
May.08.2020
FDA Reissues EUA for Non-NIOSH Approved Respirators Manufactured in China
May.06.2020
Court Tosses Complaint Against Meatpacker Alleging COVID-19 Related Health and Safety Violations
May.05.2020
FDA Tightens the Rules for Antibody (Serology) Test Manufacturers
May.01.2020
FDA Reminds Companies Manufacturing Hand Sanitizer of the Importance of Using Denatured Alcohol and Continues to Closely Monitor COVID-19 Claims
May.01.2020
FDA Turns to 503A Compounding Facilities to Mitigate COVID-19 Drug Shortages
Apr.21.2020
FDA Issues Final Guidance Aimed at Alleviating COVID-19 Drug Shortages through Outsourcing Facilities
Apr.20.2020
Business Disruption in a Pandemic: Allocating Limited Supply
Apr.17.2020
COVID-19 Class Actions: Refund Disputes Rage Over Membership Fees & Event Tickets
Apr.15.2020
NIOSH-Approved Respiratory Protective Devices Are Now "Covered Countermeasures" Against COVID-19
Apr.15.2020
Mitigating COVID-19 Related Litigation Risk in the Food Industry: Follow FDA Best Practices
Apr.14.2020
FDA Final Guidance for PPE Shortages at Sterile Compounding Pharmacies not Registered as Outsourcing Facilities
Apr.10.2020
In Response to COVID-19 Pandemic, FDA Temporarily Changes Packaging and Labelling Requirements for Shell Eggs
Apr.08.2020
FDA Recommends Social Distancing in Food Facilities to Prevent the Spread of COVID-19
Apr.07.2020
Emergency Use Authorization for Ventilators and Related Equipment
Apr.07.2020
FDA Releases New Enforcement Policy for Face Masks and Respirators
Apr.06.2020
The FDA Reverses Course and Authorizes the Importation of Non-NIOSH Approved Respirators Manufactured in China
Mar.31.2020
Businesses Face Price Gouging Concerns Amid COVID-19 Crisis
Mar.30.2020
Section 564 of the Federal Food, Drug, and Cosmetics Act: Emergency Use Authorization
Mar.27.2020
PREP Act Immunity from Liability for COVID-19 Related Medical Equipment
Mar.23.2020
Immunity Protections for Product Manufacturers and Distributors Under the PREP Act
Mar.20.2020
FDA Presses Pause on Domestic and Foreign Inspections for all FDA-Regulated Products Due To COVID-19 Concerns
Mar.19.2020
Agencies, Plaintiffs Target Ethylene Oxide
Mar.19.2020
NHTSA Announces Historic Proposal to Modernize Vehicle Safety Standards
Mar.17.2020
Does
Bristol-Myers Squibb
Apply to Nationwide Class Actions in Federal Court? The First Two Federal Circuits Weigh In
Mar.05.2020
The Fifth Circuit Creates Minimum Approximate Physical Presence Test for General Jurisdiction
Feb.19.2020
Shifting Liability: AI in Medical Devices
Feb.12.2020
FDA Enforcement Trends: Reflecting on 2019 and Looking Onward to 2020
Feb.04.2020
CBD False Advertising Claims Stayed Pending Further FDA Guidance
Feb.03.2020
It’s Déjà Vu All Over Again: Supreme Court To Revisit the Scope of Specific Jurisdiction
Jan.29.2020
OEHHA Clarifies Responsibilities and the Meaning of "Actual Knowledge" Under Prop 65 Regulations
Jan.16.2020
FDA Enforcement Trends: Reflecting on 2019 and Looking Onward to 2020
Dec.20.2019
Roundup
®
: Will EPA Have the Last Word on Glyphosate?
Dec.10.2019
FDA Cracks Down on Health Claims in CBD Advertisements
Sep.27.2019
Significant Amendments To Rule 30(b)(6) Are Being Considered And Corporate Entities Must Pay Attention
Aug.20.2019
EPA Rebuffs California Prop 65 Glyphosate Labeling
Jun.10.2019
From Roundup® to Oatmeal: The Next Trend in Glyphosate Litigation?
Jun.07.2019
Supreme Court Decision Raises New Questions on Impossibility Preemption in Cases Challenging Sufficiency of Drug Label Warnings
May.29.2019
About Face! Florida Supreme Court Adopts
Daubert
Standard— Seven Months After Rejecting It
May.13.2019
How Much Is Enough? A Judicial Roadmap to Low Dose Causation Testimony in Asbestos and Tort Litigation
Apr.08.2019
FDA Promotes Evolving Regulation of Medical Device Materials
Apr.02.2019
There May Be Hope for That Label Claim, After All: FDA Proposes to Add Additional Non-Digestible Carbs to the Definition of Dietary Fiber
Want to see more? View our archive